Pharmacy at both sides of the Atlantic It seemed to have cheated Trump’s fees last night.
Some products include copper, wood, semiconductors and energy They escaped from the payment gillotin. The sector has been preparing for impact since February Trump suggested to impose 25% of fees for drugs.
Ireland is the most exposed to pharmaceutical fees, where American companies like Faiser, Johnson & Johnson, Eli Lily, Bristol-News Squip and API Has recently changed important production activities.
Other major exporters of pharmaceutical and biotechnology products are Denmark, Belgium and Germany. In 2024, there were pharmaceutical products EU imports of the EUA total of $ 127,000 million (117,000 million euros), commercial flow This may significantly affect patients And the institutions of both parties.
But despite the opening life expectancy, the European Union is still concerned with fees that affect exemptions. “We are not sure that we can breathe peace of“A senior EU official said.
The pharmaceutical fees are an opportunity
The official said that the US has identified Five strategic parts for production and transplantation: Cars, steel and aluminum, minerals and wood, pharmaceutical products and semiconductors. Washington has already imposed the charges of cars, Steel and aluminumResearch on wood, firewood and copper has been launched.
“We believe it This is very possible – It has recommended us.- The remaining two fields (pharmaceutical and semiconductor products) begin, ”the official said,” For this possibility, the European Commission Chairman Ursula Van Ter Lainin,. Will bring representatives of the pharmaceutical department Tuesday in Brussels next week.
“We are not going to retreat in the pharmaceutical industry. It is a strategic field for Europe. And We will do everything possible to protect and encourage it“The officer also said. Drug products refer to a sector with comprehensive bilateral trade.” We offer goods to the industries of others, ”the official said that the business relationship included The most special products Shared between the two areas.
The issue created by Trump
Current American company EU’s drug export and active theories This is the result of his own policies during Trump’s first presidency. Investigations by the Senate Finance Committee, published in March by the Democrats, found that major US pharmaceutical companies had exploited a legal pipeline created by Trump’s tax reform in 2017 to transform overseas.
Companies like Fyser. They used lower -dox fundsAs Ireland, to reduce their US financial invoice. As a result, Ireland has become an important production center of US pharmaceutical products.
“If the fees are used in the future, this may be A significant economic impact on Ireland.
Pharmaceutical Health Care Association (IPHA) believes that the real impact of controversy between the White House and the EU It is only perceived as “within four or five years”Due to the chronic nature of investment in large -scale manufacturing plants.
Belgium, Headquarters of the main Faizer production plant In Europe, he exported $ 73,000 million (66,000 million euro) in pharmaceutical products 2024 to 10 months24% of them went to the United States. The pharmaceutical industry refers to 15% of the total exports of Belgium.
“Our first reaction is relieved. It said, We are still very careful and worry about the future“David Jering, written by Pharma.
